Israel: Bar-Ilan University develops molecular strategy to treat hematological cancer

BIRAD - Research and Development Co. Ltd

The study could provide an answer to types of hematological cancers for which no treatment has yet been found

Researchers at Bar-Ilan University in Israel have unveiled a new therapeutic approach in the fight against hematological cancer. 

The new method, developed by Professor Mira Barda-Saad and her research team at the Mina and Everard Goodman Faculty of Life Sciences, involves attacking the cytoskeleton protein, called WASp, which has a unique structural condition in active hematological cancer cells.

To the article>>>

Posted in